ATE43244T1 - Pharmazeutische zusammensetzung in form einer salbe zur dermischen und ophthalmischen verwendung. - Google Patents
Pharmazeutische zusammensetzung in form einer salbe zur dermischen und ophthalmischen verwendung.Info
- Publication number
- ATE43244T1 ATE43244T1 AT86107343T AT86107343T ATE43244T1 AT E43244 T1 ATE43244 T1 AT E43244T1 AT 86107343 T AT86107343 T AT 86107343T AT 86107343 T AT86107343 T AT 86107343T AT E43244 T1 ATE43244 T1 AT E43244T1
- Authority
- AT
- Austria
- Prior art keywords
- dermic
- pharmaceutical composition
- ophthalmic use
- ointment form
- active ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT20970/85A IT1190361B (it) | 1985-05-30 | 1985-05-30 | Composizione farmaceutica in crema per uso dermale ed oftalmico |
EP86107343A EP0205051B1 (de) | 1985-05-30 | 1986-05-30 | Pharmazeutische Zusammensetzung in Form einer Salbe zur dermischen und ophthalmischen Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE43244T1 true ATE43244T1 (de) | 1989-06-15 |
Family
ID=11174785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT86107343T ATE43244T1 (de) | 1985-05-30 | 1986-05-30 | Pharmazeutische zusammensetzung in form einer salbe zur dermischen und ophthalmischen verwendung. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0205051B1 (de) |
JP (1) | JPH0764745B2 (de) |
AT (1) | ATE43244T1 (de) |
DE (1) | DE3663449D1 (de) |
IT (1) | IT1190361B (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4837381A (en) * | 1986-08-11 | 1989-06-06 | American Cyanamid Company | Compositions for parenteral administration and their use |
EP0257368B1 (de) * | 1986-08-11 | 1992-03-25 | American Cyanamid Company | Zusammensetzungen zur parenteralen Verabreichung und deren Verwendung |
WO1989001489A1 (en) * | 1987-08-10 | 1989-02-23 | Commonwealth Scientific And Industrial Research Or | Control of angiogenesis and compositions and methods therefor |
US5705485A (en) * | 1987-09-18 | 1998-01-06 | Ethicon, Inc. | Gel formulations containing growth factors |
US5036046A (en) * | 1988-10-12 | 1991-07-30 | Eye Research Institute Of Retina Foundation, Inc. | Method for enhancing healing of corneal endothelial wounds |
US5051443A (en) * | 1988-10-12 | 1991-09-24 | Eye Research Institute Of Retina Foundation, Inc. | Method for enhancing healing of corneal endothelial wounds |
US5032575A (en) * | 1988-10-12 | 1991-07-16 | Eye Research Institute Of Retina Foundation, Inc. | Method for enhancing healing of corneal endothelial wounds |
JPH04305528A (ja) * | 1991-02-22 | 1992-10-28 | Dai Ichi Seiyaku Co Ltd | ケラチノサイト及び皮膚線維芽細胞の増殖刺激剤 |
ZA927277B (en) * | 1991-10-02 | 1993-05-19 | Boston Ocular Res | Dry eye treatment process and solution. |
US5290920A (en) * | 1992-04-16 | 1994-03-01 | Allelix Biopharmaceuticals Inc. | Method of purifying human epidermal growth factor |
FR2695556B1 (fr) * | 1992-09-15 | 1995-03-24 | Rochas Sa Parfums | Composition biologique contenant des EGF destinée à réguler la croissance cellulaire. |
FR2695557A1 (fr) * | 1992-09-15 | 1994-03-18 | Rochas Sa Parfums | Composition biologique contenant des EGF destinée à réguler la croissance cellulaire. |
KR102114993B1 (ko) * | 2015-10-15 | 2020-05-25 | 주식회사 파이안에스테틱스 | 폴리펩타이드 및/또는 세포 배양 여액을 함유하는 수용성 스크럽 입자를 포함하는 화장제 조성물 |
CN110652493A (zh) * | 2019-10-31 | 2020-01-07 | 福建蓝昊肽生物科技发展有限公司 | 一种增加生物活性肽乳膏稳定性的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0140998B1 (de) * | 1983-11-02 | 1989-11-15 | Nihon Chemical Research Kabushiki Kaisha | Augenpräparate |
JPS615006A (ja) * | 1984-06-19 | 1986-01-10 | Sanki Shoji Kk | 皮膚用剤 |
-
1985
- 1985-05-30 IT IT20970/85A patent/IT1190361B/it active
-
1986
- 1986-05-29 JP JP61125583A patent/JPH0764745B2/ja not_active Expired - Lifetime
- 1986-05-30 EP EP86107343A patent/EP0205051B1/de not_active Expired
- 1986-05-30 AT AT86107343T patent/ATE43244T1/de not_active IP Right Cessation
- 1986-05-30 DE DE8686107343T patent/DE3663449D1/de not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE3663449D1 (en) | 1989-06-29 |
IT8520970A0 (it) | 1985-05-30 |
JPS6227A (ja) | 1987-01-06 |
EP0205051A1 (de) | 1986-12-17 |
IT1190361B (it) | 1988-02-16 |
EP0205051B1 (de) | 1989-05-24 |
JPH0764745B2 (ja) | 1995-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE43244T1 (de) | Pharmazeutische zusammensetzung in form einer salbe zur dermischen und ophthalmischen verwendung. | |
ATE73331T1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
ZA885192B (en) | Pharmaceutical preparations | |
CA2068324A1 (en) | Metal-peptide compositions and methods for stimulating hair growth | |
NO170194C (no) | Fremgangsmaate for fremstilling av fysiologisk aktive saarhelingsstoffer | |
DE3875425T2 (de) | Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen. | |
DE3772139D1 (de) | Kosmetische zusammensetzung. | |
DE3588023D1 (de) | Mittel zur Behandlung von Herzerkrankungen. | |
ES2181682T3 (es) | Utilizacion de licopeno para reducir la actividad de las celulas, en particular celulas cancerosas y preparaciones farmaceuticas. | |
ATE55695T1 (de) | Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien. | |
DE69535081D1 (de) | Verwendung von Prostaglandin A oder dessen Derivaten zur Behandlung von Psoriasis | |
ATE206914T1 (de) | Verwendung von ursolsäure zur herstellung eines arzneimittels zur unterdrückung von metastasen | |
DE3850154T2 (de) | Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression. | |
IT1240683B (it) | Composizione farmaceutica contenente egf | |
SE8703210L (sv) | Hudvardskompositioner med keratolytisk och antiinflammatorisk aktivitet | |
AU629445B2 (en) | Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol | |
ATE136465T1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
ATE45675T1 (de) | Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen. | |
FR2616325B1 (fr) | Composition contenant de l'hydroquinone et de l'acide kojique et composition pharmaceutique, notamment dermatologique, a activite depigmentante ou anti-inflammatoire, ou cosmetique comprenant de l'acide kojique et de l'hydroquinone | |
ATE66375T1 (de) | Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von verschiedenen erkrankungen des menschen in niedriger dosierung. | |
FR2392674A1 (fr) | Compositions pharmaceutiques a base d'elastine | |
IT8520514A0 (it) | Composizioni di farmaci dotate di attivita' antimicrobica eprocedimento per la loro preparazione. | |
DE3665403D1 (en) | Pharmaceutical composition for topical application | |
ATE56360T1 (de) | Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma. | |
ATE53384T1 (de) | 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |